Search Results for 'week hiv'

week hiv published presentations and documents on DocSlides.

Essentials for Optimal Care of HIV Patients
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
ID Week 2016: HIV Update
ID Week 2016: HIV Update
by min-jolicoeur
Robert Harrington, M.D.. ID Week 2016: HIV Update...
Lower than Expected HIV Incidence among Men and Women at Elevated
Lower than Expected HIV Incidence among Men and Women at Elevated
by harmony
HIV Risk in a Population-based . PrEP. Study in R...
How can  programmes  best support female sex workers to avoid HIV infection in Zimbabwe?
How can programmes best support female sex workers to avoid HIV infection in Zimbabwe?
by faustina-dinatale
A prevention cascade analysis. Elizabeth Fearon, ...
Management of HCV in Co-Infected Patients
Management of HCV in Co-Infected Patients
by danika-pritchard
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
3 D (Paritaprevir-Ritonavir-Ombitasvir
3 D (Paritaprevir-Ritonavir-Ombitasvir
by aaron
. + Dasabuvir) + RBV in GT1 . TURQUOISE-I. Phase...
CROI Update: Best of Boston
CROI Update: Best of Boston
by triclin
p. resented by. NCATEC. March . 18, . 2014. David ...
DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
by maximus
DRIVE FORWARD. Doravirine. + 2 NRTIs vs. Darunavi...
New and Investigational ART Drugs and Strategies
New and Investigational ART Drugs and Strategies
by elina
Judith S. Currier, MD, . MSc. Division of Infectio...
1 Yale University School of Medicine, New Haven, United States,
1 Yale University School of Medicine, New Haven, United States,
by thomas
2. Icahn School of Medicine at Mount Sinai, New Yo...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Faculty W. David Hardy, MD, AAHIVS
Faculty W. David Hardy, MD, AAHIVS
by christina
Scientific and Medical Consultant. Adjunct Clinica...
PrEP Cases Kevin L. Ard, MD, MPH Massachusetts General Hospital
PrEP Cases Kevin L. Ard, MD, MPH Massachusetts General Hospital
by alexa-scheidler
PrEP Cases Kevin L. Ard, MD, MPH Massachusetts Ge...
PrEP  201: Beyond the Basics
PrEP 201: Beyond the Basics
by stefany-barnette
Joanne . Stekler. , MD MPH. Associate Professor o...
NUR 120  Week 6 Immune Disorders
NUR 120 Week 6 Immune Disorders
by briana-ranney
Infection. Human Immunodeficiency Virus. Genetics...
NUR 120  Week 6 Immune Disorders
NUR 120 Week 6 Immune Disorders
by liane-varnes
Infection. Human Immunodeficiency Virus. Genetics...
Bringing the test to the patient: methods and tools for integrating innovative point-of-care HIV te
Bringing the test to the patient: methods and tools for integrating innovative point-of-care HIV te
by marina-yarberry
Leadership Workshop, 22. nd. International AIDS ...
Antiretroviral Updates:
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...
Innovative Strategies for the Management
Innovative Strategies for the Management
by karlyn-bohler
of HIV Infection. Dual therapies without NRTIs. J...
Switching to  Bictegravir
Switching to Bictegravir
by emery
/. Emtricitabine. /. Tenofovir. . Alafenamide. (...
Emergence of resistance in
Emergence of resistance in
by emma
HIV-1 Integrase . following dolutegravir (DTG) tre...
Patricia A. Cioe, PhD 1 , Alexander W. Sokolovsky, PhD
Patricia A. Cioe, PhD 1 , Alexander W. Sokolovsky, PhD
by rodriguez
1. , Judson A. Brewer, M.D., PhD. 1. , Christopher...
Fostemsavir in Treatment-Experienced Patients
Fostemsavir in Treatment-Experienced Patients
by joanne
BRIGHTE Study (Week 48 Data). Fostemsavir (FTR) fo...
1 University of Nebraska Medical Center, Omaha, NE, United States;
1 University of Nebraska Medical Center, Omaha, NE, United States;
by min-jolicoeur
1 University of Nebraska Medical Center, Omaha, N...
Efficacy and Safety of  Doravirine
Efficacy and Safety of Doravirine
by giovanna-bartolotta
. 100mg. . QD. . vs . Efavirenz . 600mg. . QD...
A  C omparison  of  Daily
A C omparison of Daily
by debby-jeon
and . Non-daily . Pre-exposure . P. rophylaxis Do...
TURQUOISE-I:
TURQUOISE-I:
by tawny-fly
SAFETY AND EFFICACY OF ABT-450/R/OMBITASVIR, DASA...
Tenofovir   Alafenamide  (TAF)
Tenofovir Alafenamide (TAF)
by nicole
in a Single-Tablet Regimen . in Initial HIV-1 Ther...
1 Queen Mary University, London, United Kingdom;
1 Queen Mary University, London, United Kingdom;
by trish-goza
1 Queen Mary University, London, United Kingdom; ...
Switching From a  Tenofovir
Switching From a Tenofovir
by yael
. Disoproxil. . Fumarate. (TDF)-Based Regimen to...
Wisdom Healing Qigong Eight week class results
Wisdom Healing Qigong Eight week class results
by blondield
Chronic Pain. Well-being / Global Distress. Includ...
Comparison of RTV vs Cobi
Comparison of RTV vs Cobi
by studmonkeybikers
GS-US-216-0114. . Gallant JE. JID 2013;208:32-9...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...